| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |